Q-linea AB (publ)
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, European Union, the Middle East, and the United States. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, includin… Read more
Q-linea AB (publ) (3F80) - Total Assets
Latest total assets as of June 2025: €201.00 Million EUR
Based on the latest financial reports, Q-linea AB (publ) (3F80) holds total assets worth €201.00 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Q-linea AB (publ) - Total Assets Trend (2021–2024)
This chart illustrates how Q-linea AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Q-linea AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
Q-linea AB (publ)'s total assets of €201.00 Million consist of 65.5% current assets and 34.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 17.3% |
| Accounts Receivable | €842.00K | 0.6% |
| Inventory | €33.19 Million | 22.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €42.00K | 0.0% |
| Goodwill | €4.89 Million | 3.3% |
Asset Composition Trend (2021–2024)
This chart illustrates how Q-linea AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Q-linea AB (publ)'s current assets represent 65.5% of total assets in 2024, an increase from 51.3% in 2021.
- Cash Position: Cash and equivalents constituted 17.3% of total assets in 2024, up from 3.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 1.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 22.4% of total assets.
Q-linea AB (publ) Competitors by Total Assets
Key competitors of Q-linea AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Q-linea AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Q-linea AB (publ) generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Q-linea AB (publ) is currently not profitable relative to its asset base.
Q-linea AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.54 | 1.19 | 1.19 |
| Quick Ratio | 4.50 | 0.70 | 0.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €125.34 Million | € 15.73 Million | € 15.73 Million |
Q-linea AB (publ) - Advanced Valuation Insights
This section examines the relationship between Q-linea AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -36.2% |
| Total Assets | €147.99 Million |
| Market Capitalization | $9.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Q-linea AB (publ)'s assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Q-linea AB (publ)'s assets decreased by 36.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Q-linea AB (publ) (2021–2024)
The table below shows the annual total assets of Q-linea AB (publ) from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €147.99 Million | -36.20% |
| 2023-12-31 | €231.98 Million | +0.90% |
| 2022-12-31 | €229.92 Million | -52.54% |
| 2021-12-31 | €484.46 Million | -- |